UK markets open in 4 hours 34 minutes
NIKKEI 225
39,120.32 +50.64 (+0.13%) HANG SENG
19,285.48 -350.74 (-1.79%) CRUDE OIL
79.62 -0.18 (-0.23%) GOLD FUTURES
2,421.70 -16.80 (-0.69%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
55,849.11 +3,396.34 (+6.48%)
Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.87B |
| Enterprise value | 2.59B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.34k |
| Price/book (mrq) | 4.21 |
| Enterprise value/revenue | 1.36k |
| Enterprise value/EBITDA | -3.31 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.65 |
| 52-week change 3 | 14.24% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 18.33 |
| 52-week low 3 | 3.21 |
| 50-day moving average 3 | 12.91 |
| 200-day moving average 3 | 8.60 |
Share statistics
| Avg vol (3-month) 3 | 7.06M |
| Avg vol (10-day) 3 | 6.89M |
| Shares outstanding 5 | 279.83M |
| Implied shares outstanding 6 | 286.54M |
| Float 8 | 207.36M |
| % held by insiders 1 | 0.54% |
| % held by institutions 1 | 89.46% |
| Shares short (30 Apr 2024) 4 | 50.06M |
| Short ratio (30 Apr 2024) 4 | 11.93 |
| Short % of float (30 Apr 2024) 4 | 19.96% |
| Short % of shares outstanding (30 Apr 2024) 4 | 17.89% |
| Shares short (prior month 28 Mar 2024) 4 | 46.38M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 26 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -16,464.61% |
Management effectiveness
| Return on assets (ttm) | -34.48% |
| Return on equity (ttm) | -66.77% |
Income statement
| Revenue (ttm) | 1.9M |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -451.03M |
| Net income avi to common (ttm) | -449.64M |
| Diluted EPS (ttm) | -1.81 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 356.2M |
| Total cash per share (mrq) | 1.27 |
| Total debt (mrq) | 84.37M |
| Total debt/equity (mrq) | 12.41% |
| Current ratio (mrq) | 4.63 |
| Book value per share (mrq) | 2.43 |
Cash flow statement
| Operating cash flow (ttm) | -384.28M |
| Levered free cash flow (ttm) | -231.84M |
© 2024 Yahoo. All rights reserved.